Dr. Ceron is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Novartis Pharmaceuticals
1 Health Plaza
East Hanover, NJ 07936
Education & Training
- Charles R Drew UniversityResidency, Ophthalmology, 2000 - 2003
- Tulane UniversityInternship, Internal Medicine, 1999 - 2000
- Creighton University School of MedicineClass of 1999
Certifications & Licensure
- CA State Medical License 2001 - 2025
- LA State Medical License 2000 - 2025
- MA State Medical License 2006 - 2025
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Publications & Presentations
PubMed
- 111 citationsThe Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management.C. Stephen Foster, Srishti Kothari, Stephen D Anesi, Albert T. Vitale, David S. Chu
Survey of Ophthalmology. 2016-01-01 - 102 citationsA comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.Cheryl A. Arcinue, Olga M Cerón, C. Stephen Foster
Journal of Ocular Pharmacology and Therapeutics. 2013-05-31 - 12 citationsA retrospective analysis of triple combination therapy with intravitreal bevacizumab, posterior sub-tenon's triamcinolone acetonide, and low-fluence verteporfin photod...Kyle D. Kovacs, Matthew T. Quirk, Taiga Kinoshita, Shiva Gautam, Olga Ceron
Retina. 2011-03-01
Press Mentions
- Ebola-Related Eye Problems Hit Second US SurvivorJanuary 13th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: